A novel IgM intranasal intervention against SARS-CoV-2

Antib Ther. 2021 Aug 28;4(3):171-174. doi: 10.1093/abt/tbab019. eCollection 2021 Jul.

Authors

Antony Yerabham¹, Mitchell Ho^{1

2}

Affiliations

¹ Antibody Engineering Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
² Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

No abstract available

Keywords: COVID-19; IgM; SARS-CoV-2; intranasal delivery; neutralizing antibodies; receptor-binding domain (RBD).

Publication types

News

Grants and funding